The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is new in chronic GvHD?

Dec 12, 2019

The GvHD Hub are proud to present expert interviews directly from the 61st American Society of Hematology (ASH) meeting in Orlando, US. This interview with Steven Pavletic, National Cancer Institute, Bethesda, US, was based on the question: What is new in chronic graft-versus-host disease?

Steven Pavletic gives a comprehensive overview of the evolving field of chronic GvHD. He also discusses clinical trials, FDA approvals and novel interventions for the prevention and treatment of GvHD.

What is new in chronic GvHD?